NCT02017600 - A Phase II Trial of Induction Chemotherapy With ND-420, Cisplatin and Fluorouracil Followed by Surgery in the Treatment of Patients With Localized Squamous Cell Carcinoma of the Esophagus | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

December 2, 2014

Study Completion Date

April 4, 2015

Conditions

Localized Squamous Cell Carcinoma of the Esophagus

Interventions

DRUG

ND-420

ND-420 50 mg/m2 on day1

PROCEDURE

Surgery

After induction chemotherapy, participants will be receive right or left thoracotomy for curative resection by total or subtotal thoracic esophagectomy.

DRUG

Cisplatin

cisplatin 70 mg/m2 on day1

DRUG

fluorouracil

fluorouracil 700 mg/m2 daily, day1 to day4

Trial Locations (1)

112

Taipei Veterans General Hospital, Taipei